On any given day, the Sandra and Edward Meyer Cancer Center is alive with activity; the labs are filled with brilliant scientists working together to solve some of medicine’s most challenging mysteries.
Weill Cornell Medicine marked an extraordinary year in 2015, capped by launching a new name that exemplifies the unprecedented clinical growth, scientific advancement and educational accomplishments that have cemented the institution as a driving force in healthcare.
When Tracy Branick met Dr. Ted Schwartz, director of the Center for Epilepsy and Anterior Skull Base and Pituitary Surgery at Weill Cornell Medicine, she was immediately put at ease. He was warm, kind and confident that he could help her treat the epileptic seizures that were affecting her daily life.
A significant gift to Weill Cornell Medicine’s leading precision medicine program by Caryl and Overseer Israel Englander will expand the scope of the institution’s approach to understanding and treating disease through therapies customized to patients’ unique genetic profiles.
Weill Cornell Medicine is among the top-ranked clinical and medical research centers in the country, providing the best possible medical care to our patients, educating the health care leaders of tomorrow and speeding breakthrough discoveries from the lab bench to the patient bedside. At our core is a vision of physician-scientists working together, across disciplines, to accomplish these goals and continue providing world-class care to our patients, who are at the heart of our every endeavor.
With the recent opening of the state-of-the-art Belfer Research Building, we are positioned to greatly expand and accelerate our research program, bringing even more leading lights to our campus. We know that we are the right place and that this is the right time for Weill Cornell Medicine to be at the center of a transformation in medicine.
Weill Cornell Medicine continues to build on its track record of unprecedented growth. With a leading team of physician-scientists and the newest technology at our fingertips, we are perfectly poised to usher in a new era of personalized and 'tailored' medicine at our institution. We remain committed to keeping our students on the frontlines of medicine, and providing our faculty with the best opportunities and resources possible. As we look toward the future, there are myriad opportunities on the horizon.
Donors are the cornerstone of our work at Weill Cornell Medicine, helping us
lead the way in innovative treatments and pioneering research, pairing
medical education and the latest in technologies with a commitment to
compassionate and person-to-person care.
You are the agents of change in
advancing medicine and patient care.
— Jessica M. Bibliowicz
Chairman of the Board of Overseers, Weill Cornell Medicine